isabelobrien, Author at European Medical Journal - Page 66 of 70

Talking to Claudia Martinez

GOLD sits down with Claudia Martinez, Research Programme Manager, Access to Medicine Foundation, who explains the methodology behind the Access to Medicine Foundation’s 2021 Index, why access to medicine is still a challenge for the pharmaceutical industry and how companies can adapt their processes to reach to most vulnerable patient populations.

Talking to Arpita Pani

GOLD is joined in the studio by Arpita Pani, Senior Commercial Governance, Digital and E-Commerce Lead at Ferring Pharmaceuticals, to discuss the evolution and future of digital marketing in pharma, including the industry’s use of social media.

Talking to Julien De Salaberry

GOLD discusses digital health with Julien De Salaberry, an expert in health tech, who has worked across the pharma and start-up sectors, striving to solve healthcare pain points with technological innovation.

Congress postponed... What next?

Professor Jonathan Sackier discusses COVID-19 myths and why pharma needs to find alternative ways to share research.

Hey Siri, can I trust you with my health?

While health tech is not set to drive pharma out of business, it is essential that the industry incorporates it into future strategies.

Gravitating towards planet centricity

It is time for the pharmaceutical industry to recognise their duty of care to the planet as well as patients, and drastically reduce their carbon footprint.

How do you solve a problem like pharma waste?

Amidst the public discourse surrounding sustainability and ethical practices, is the problem of pharmaceutical waste. It is imperative that the pharmaceutical industry actively seeks solutions.

Merz's Dr Terri L. Phillips on championing equality in the workplace

Dr Terri L. Phillips, Vice President and Head Global Medical Affairs, Merz, speaks to us about championing women in the workplace, her experience in the US army medical corps, and the changing nature of medical affairs.

Access to Medicine: Mission Possible

Globally, 5 billion people have access to medication, leaving 2 billion, predominantly in the developing world, who do not. As a challenge that only continues to grow in complexity, with ever-changing regulations and continual development of treatments, market access appears to be the pharmaceutical industry’s mission impossible

The history of pharma marketing

Over the past two centuries, the landscape of pharmaceutical marketing has transformed almost beyond recognition. We reflect on the propelling reasons behind such metamorphic change and consider the impact of emerging platforms: from print to radio and from TV to online.